Dravon Medical, Inc.

Name of License: 
Dravon Medical, Inc.
By the: 
Department of Veterans Affairs, Office of Research and Development (VA)
Summary 

A mask can comprise a covering material that is sufficiently sized to extend over a mouth and a
nose on a head of a wearer. The covering material can have an outer surface and an inner
surface. The covering material can define an opening therethrough. At least one transparent
membrane can be coupled to the covering material and cover the opening in the covering
material. The at least one transparent membrane can define a hole therethrough. An elongate
conduit can define an interior passage having a central axis. The elongate conduit can be
coupled to the at least one transparent membrane so that the central axis of the interior passage is
aligned with the hole. The mask can further comprise at least one securing element for securing
the mask to the head of the wearer.

Tech Name: 
Nasal Endoscopy AGP Mask
Action: 
Intent
Dates: 
Comments must be received by September 3, 2021
Address: 
Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420
For further information contact 

Send comments to Dr. Lee A. Sylvers, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (813) 505-6989 (this is not a toll-free number), Email: lee.sylvers@va.gov

Supplementary information 

The Federal Government’s patent rights in this invention are assigned to the US Government as represented by the Department of Veterans Affairs. It is in the public interest to license this invention to Dravon Medical, Inc. as they have submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development, Technology Transfer Program receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.